About INFINITY BIO, INC.
Infinity Bio is a biotechnology company specializing in antibody reactome analysis using its proprietary MIPSA technology to decode immune responses against various antigens, including viruses, allergens, and proteins. The company provides services for research in infectious diseases, autoimmune disorders, vaccine development, allergy research, and cancer immunotherapy.
Antibody reactivity profiling using MIPSA technologyCustom antigen library developmentHuman and mouse protein peptide library analysisEnvironmental and allergen exposure profilingViral antigen analysisHigh-throughput sample processingBioinformatics and data science support
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| VIRSIGHT PROFILING FROM AFRICAN MOSQUITO BLOODMEALS (AMBIS # 2248955) | Department of Health and Human Services | $11K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INFINITY BIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.